Aboleris Holdco
The computed 12-month bankruptcy probability of Aboleris Holdco is 1.0% (low). The 2024 annual accounts show equity of €12.60M and a net result of €-7.78M. Its solvency ranks better than 95% of 42 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €12.60M |
| Net result | €-7.78M |
| Better than sector | 95% |
| Active | 3 yrs |
Strong profile, led by solvency.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 95.0% | 53.6% | |
| Net result | €-7.78M | €-16k | |
| Equity | €12.60M | €644k | |
| Gross operating margin | €-7.81M | €7k | |
| Total assets | €13.27M | €1.71M |
| Fiscal year | 2024 |
|---|---|
| Deposit | volledig |
| Revenue | - |
| EBITDA | €-7.81M |
| Net profit | €-7.78M |
| Cash flow | €-7.77M |
| Staff costs | - |
| Income taxes | €3 |
| Dividends | - |
| Total assets | €13.27M |
| Equity | €12.60M |
| Debt | €667k |
| of which ≤ 1y | €667k |
| of which > 1y | - |
| Working capital | €2.84M |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 5.25 |
| Quick ratio | 5.25 |
| Working capital ratio | 21.4% |
| Solvency | 95.0% |
| Debt / equity | 0.05 |
| Long-term debt ratio | - |
| Interest coverage | -181.55 |
| Gross margin | - |
| Net margin | - |
| ROA | -58.7% |
| ROE | -61.8% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €13.27M |
| Fixed assets | 21/28 | €9.76M |
| Formation expenses | 20 | €0 |
| Intangible fixed assets | 21 | €8k |
| Tangible fixed assets | 22/27 | €7k |
| Financial fixed assets | 28 | €9.75M |
| Current assets | 29/58 | €3.50M |
| Amounts receivable within one year | 40/41 | €228k |
| Cash & bank | 54/58 | €3.26M |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €13.27M |
| Equity | 10/15 | €12.60M |
| Contributions / capital | 10/11 | €23.49M |
| Accumulated profits (losses) | 14 | €-10.89M |
| Amounts payable | 17/49 | €667k |
| Amounts payable within one year | 42/48 | €667k |
| Trade debts payable within one year | 44 | €667k |
| Income statement | ||
| Gross operating margin | 9900 | €-7.81M |
| Operating result | 9901 | €-7.82M |
| Financial income | 75 | €80k |
| Financial charges | 65 | €43k |
| Result before taxes | 9903 | €-7.78M |
| Income taxes | 67/77 | €3 |
| Net result for the period | 9904 | €-7.78M |
| Result to be appropriated | 9905 | €-7.78M |
-
Biotech corporate devLegal entityManaging director· perm. rep.: Frédéric LegrosState Gazette act 24448711 (05-12-2024)Current05-12-2024 → present
-
Criteria Bio Ventures SICC SALegal entityManaging director· perm. rep.: Pablo Cironi LópezState Gazette act 24448711 (05-12-2024)Current05-12-2024 → present
-
Sound Bioventures Management ABLegal entityManaging director· perm. rep.: Bibhash MukhopadhyayState Gazette act 24448711 (05-12-2024)Current05-12-2024 → present
Former directors (2)
-
Bibhash MukhopadhyayManaging directorState Gazette act 24448711 (05-12-2024)Former- → 05-12-2024
-
Pablo Cironi LópezManaging directorState Gazette act 24448711 (05-12-2024)Former- → 05-12-2024
| NACE primary | Speur- en ontwikkelingswerk op biotechnologisch gebied(72101) |
| Legal form | Public limited company(014) |
| Incorporation | 27-06-2023 |
| Status | Active |
| Postal code | 6041 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52028B0323/00M003 | Wallonia | 8,679 m² | 1 · 791 m² | 18.8 m · 5 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
16-09-2025 3 directors appointed
- Laurent Verhavert, Directeur
- Simon Bizimana, Directeur
- Strelia, Directeur
Technical details
{
"events": [
{
"kind": "rep_rotation",
"role": "directeur",
"person": {
"rrn": null,
"name": "Guillaume Heynen",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Newton Biocapital Partners",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Les administrateurs prennent acte du remplacement de Mr. Guillaume Heynen par Mr. Alain Parthoens comme repr\u00E9sentant permanent de l\u0027administrateur Newton Biocapital Partners.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": "Alain Parthoens",
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "rep_rotation",
"role": "directeur",
"person": {
"rrn": null,
"name": "Bibhash Mukhopadhyay",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Sound Bioventures Management AB",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Les administrateurs prennent acte du remplacement de Mr. Bibhash Mukhopadhyay par Mr. Casper Breum comme repr\u00E9sentant permanent de l\u0027administrateur Sound Bioventures Management A\u0412.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": "Casper Breum",
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "directeur",
"person": {
"rrn": null,
"name": "Laurent Verhavert",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Les administrateurs donnent procuration \u00E0 Laurent Verhavert, Simon Bizimana et tout autre avocat ou employ\u00E9 du cabinet Strelia ayant tous leurs bureaux situ\u00E9s rue de la R\u00E9gence 52, 1000 Bruxelles, chacun agissant individuellement et avec pouvoir de substitution, afin d\u0027accomplir toutes les formalit\u00E9",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "directeur",
"person": {
"rrn": null,
"name": "Simon Bizimana",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Les administrateurs donnent procuration \u00E0 Laurent Verhavert, Simon Bizimana et tout autre avocat ou employ\u00E9 du cabinet Strelia ayant tous leurs bureaux situ\u00E9s rue de la R\u00E9gence 52, 1000 Bruxelles, chacun agissant individuellement et avec pouvoir de substitution, afin d\u0027accomplir toutes les formalit\u00E9",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "directeur",
"person": null,
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Strelia",
"address": "rue de la R\u00E9gence 52, 1000 Bruxelles",
"country": "BE",
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Les administrateurs donnent procuration \u00E0 Laurent Verhavert, Simon Bizimana et tout autre avocat ou employ\u00E9 du cabinet Strelia ayant tous leurs bureaux situ\u00E9s rue de la R\u00E9gence 52, 1000 Bruxelles, chacun agissant individuellement et avec pouvoir de substitution, afin d\u0027accomplir toutes les formalit\u00E9",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-09-16",
"filing_date": "2025-09-08",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2025-06-10",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0803.217.012",
"name_full": "ABOLERIS HOLDCO",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Strelia",
"person_name": null,
"org_rep_person_name": "Simon Bizimana",
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}14-04-2025 Capital increase of €7,499,508 to €30,988,985
- €23.489.477 → €30.988.985
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 30988985.0,
"delta_eur": 7499508.0,
"before_eur": 23489477.0,
"share_emission": {
"agio_eur": 7499508.0,
"share_form": "no_nominal_value",
"share_class": "A",
"n_new_shares": 53188,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 141.0
},
"decrease_purpose": null,
"contribution_type": "numeraire",
"paid_up_delta_eur": 7499508.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "BERQUIN NOTAIRES",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2025-04-14",
"filing_date": "2025-04-10",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2025-04-02",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0803.217.012",
"name_full": "Aboleris Holdco",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition du proc\u00E8s-verbal",
"liste de pr\u00E9sence",
"neuf procurations",
"le rapport de l\u0027organe d\u0027administration",
"le rapport du commissaire \u00E9valuant",
"le texte coordonn\u00E9 des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 20000,
"class_name": "Ordinaires",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 22500,
"class_name": "Seed A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 1263,
"class_name": "Seed A\u0027",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 151866,
"class_name": "Pr\u00E9f\u00E9rentielles A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}05-12-2024 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": null,
"notary": {
"name": "Kim Lagae",
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-12-05",
"filing_date": "2024-12-03",
"act_kind_objet": "DEMISSIONS, NOMINATIONS, DIVERS"
},
"decision": {
"body": "enig_aandeelhouder_schriftelijk",
"act_date": "2024-01-22",
"unanimous": true
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0803.217.012",
"name": "Aboleris Holdco",
"role": "other",
"address": "Rue Antoine de Saint-Exup\u00E9ry 14, 6041 Charleroi",
"is_foreign": false,
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": "0803.336.281",
"name": "Criteria Bio Ventures SICC SA",
"role": "contributor",
"address": null,
"is_foreign": true,
"legal_form": "SA",
"is_new_company": false,
"jurisdiction_country": "ES"
},
{
"kbo": null,
"name": "Sound Bioventures Management AB",
"role": "contributor",
"address": null,
"is_foreign": true,
"legal_form": "AB",
"is_new_company": false,
"jurisdiction_country": "SE"
},
{
"kbo": null,
"name": "Biotech corporate dev",
"role": "contributor",
"address": "35 quai Jean Pierre Fougerat, 44220 Coueron",
"is_foreign": true,
"legal_form": null,
"is_new_company": false,
"jurisdiction_country": "FR"
}
],
"exchange_ratio": null,
"legal_articles": [
"7:133"
],
"is_cross_border": true,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": null,
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0803.217.012",
"name_full": "Aboleris Holdco",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale a pris acte de la d\u00E9mission de deux administrateurs et a nomm\u00E9 trois nouveaux administrateurs, dont deux soci\u00E9t\u00E9s \u00E9trang\u00E8res et une soci\u00E9t\u00E9 fran\u00E7aise, pour une dur\u00E9e de six ans.",
"co_filed_documents": [
"une copie des d\u00E9cisions \u00E9crites"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "director_changes"
}25-04-2024 Capital increase of €7,900,000 to €23,489,477
- €15.589.477 → €23.489.477
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 23489477.0,
"delta_eur": 7900000.0,
"before_eur": 15589477.0,
"share_emission": {
"agio_eur": null,
"share_form": "nominal",
"share_class": "A",
"n_new_shares": 63198,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 7900000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Kim LAGAE",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-04-25",
"filing_date": "2024-04-23",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e g\u00E9n\u00E9rale extraor-dinaire des actionnaires",
"act_date": "2024-04-17",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0803.217.012",
"name_full": "Aboleris Holdco",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition conforme de l\u0027acte",
"procurations",
"Rapport sp\u00E9cial du conseil d\u0027administration",
"Rapport sp\u00E9cial du commissaire",
"coordination des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 20000,
"class_name": "Ordinaires",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 22500,
"class_name": "Seed A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 1263,
"class_name": "Seed A\u0027",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 98678,
"class_name": "Pr\u00E9f\u00E9rentielles A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}16-04-2024 Registered office moved to Gosselies
- rue Antoine Saint-Exupéry 14 à 6041 Gosselies
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "rue Antoine Saint-Exup\u00E9ry 14 \u00E0 6041 Gosselies",
"city": "Gosselies",
"region": "waals_gewest",
"street": "Antoine Saint-Exup\u00E9ry",
"country": "BE",
"postcode": "6041",
"box_number": null,
"street_number": "14",
"locality_suffix": null
},
"old_address": null,
"effective_date": "2024-05-01",
"evidence_quote": "",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "missing",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "future",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-04-16",
"filing_date": null,
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "algemene_vergadering",
"date": "2024-04-05",
"unanimous": null
},
"subject_company": {
"kbo": "0803.217.012",
"name_full": "ABOLERIS HOLDO",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "BDO R\u00E9viseurs d\u0027Entreprises SRL",
"person_name": null,
"org_rep_person_name": "S\u00E9bastien Jaspar",
"person_role_at_subject": null
},
"co_filed_documents": [
"Bijlagen bij bij het het Belgisch Staatsblad",
"Annexes du Moniteur belge"
]
}20-07-2023 Capital increase of €6,150,000 to €15,589,477
- €9.439.477 → €15.589.477
- Inbreng in geld · Apport en numéraire
- 2 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 9439477.0,
"delta_eur": 720000.0,
"before_eur": 8719477.0,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Newton Biocapital I",
"share_class": "A",
"liberation_pct": 100.0,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": 2880,
"contribution_amount_eur": 720000.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": "pair_comptable",
"share_class": "A",
"n_new_shares": 2880,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": 720000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 15589477.0,
"delta_eur": 6150000.0,
"before_eur": 9439477.0,
"share_emission": {
"agio_eur": null,
"share_form": "pair_comptable",
"share_class": "A",
"n_new_shares": 24600,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 250.0
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 6150000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Kim LAGAE",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2023-07-20",
"filing_date": "2023-07-18",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e g\u00E9n\u00E9rale extraordinaire",
"act_date": "2023-07-10",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "CdP NB\u0026C\u00B0 SRL, R\u00E9viseurs d\u2019entreprises",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "Jean Nicolet"
},
"subject_company": {
"kbo": "0803.217.012",
"name_full": "Aboleris Holdco",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"rapports",
"coordination des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 27440,
"class_name": "Actions Pr\u00E9f\u00E9rentielles A",
"capital_share_eur": 9439477.0,
"voting_rights_per_share": 1.0
}
]
}12-07-2023 Capital increase of €5,519,264.03 to €8,719,477
- €3.200.212,97 → €8.719.477
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8719477.0,
"delta_eur": 5519264.03,
"before_eur": 3200212.97,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Investisseurs d\u2019actions de la soci\u00E9t\u00E9 Aboleris Pharma",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": "natura",
"n_shares_subscribed": 32765,
"contribution_amount_eur": 5519264.03
}
],
"share_emission": {
"agio_eur": null,
"share_form": "pair_comptable",
"share_class": null,
"n_new_shares": 32765,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "apport_nature",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Kim LAGAE",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2023-07-12",
"filing_date": "2023-07-10",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": null,
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "CDP NICOLET, BERTRAND \u0026 C\u00B0 R\u00E9viseurs d\u2019entreprises SRL",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "Jean NICOLET"
},
"subject_company": {
"kbo": "0803.217.012",
"name_full": "Aboleris Holdco",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition conforme de l\u2019acte",
"procurations",
"coordination des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 51763,
"class_name": "Gewone Aandelen",
"capital_share_eur": 8719477.0,
"voting_rights_per_share": 1.0
}
]
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | Aboleris Holdco |